A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Maryland
-
Rockville, Maryland, United States, 20850
- Walter Reed Army Institute of Research
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
Patients must have the following:
- Stage 1 or 2 Walter Reed clinical staging of HIV infected individuals.
- The ability to understand and sign a written informed consent form, which must be obtained prior to study entry.
- Be available for 24 weeks so that follow up may be completed.
- Qualify for care as Department of Defense health care beneficiary.
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
- Prior history of clinically significant cardiac, pulmonary, hepatic, renal, neurologic or autoimmune disease, other than HIV-1 infection, and in less than average general health as determined by a medical history, physical examination, and the required laboratory test results.
Concurrent Medication:
Excluded:
- Corticosteroids or other known immunosuppressive drugs.
- Any experimental agents.
Patients with the following are excluded:
- Prior history of clinically significant cardiac, pulmonary, hepatic, renal, neurologic or autoimmune disease, other than HIV-1 infection, and in less than average general health as determined by a medical history, physical examination, and the required laboratory test results.
Prior Medication:
Excluded within 30 days of study entry:
- Zidovudine or other anti-retroviral agents.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 075A
- V0200g
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.